Logo Image
News
Media
PodcastsCase Based Peer PerspectivesClinical Forum InsightsInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesShortsSpecial ReportVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement
|Articles|August 8, 2011

Complications of Hysteroscopy

Author(s)Ashraf Fouda, MD
Advertisement
Advertisement
Gynecologic Oncology

Related Content

Advertisement
Image credit: Society of Family Planning

Society of Family Planning issues first guidance on deep and nonpalpable contraceptive implant removal

ByJoshua Fitch, Senior Editor
September 10th 2026
Phase 3 LUNA study: atogepant reduces menstrual migraine days vs. placebo

Phase 3 LUNA study: atogepant reduces menstrual migraine days vs. placebo

ByJoshua Fitch, Senior Editor
September 10th 2026
PMOS Awareness Month: Watch our expert panel discussion on PMOS

PMOS Awareness Month: Watch our expert panel discussion on PMOS

ByJoshua Fitch, Senior Editor
September 9th 2026
Kevin Ault, MD, on the clinician's role in maternal COVID-19 vaccine counseling

Kevin Ault, MD, on the clinician's role in maternal COVID-19 vaccine counseling

ByKevin Ault, MD
September 9th 2026
Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS

Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS

ByJoshua Fitch, Senior Editor
September 9th 2026

Latest CME

Join Us at The Pathology Meeting in Las Vegas
In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 5, 2026

View more
Join Us at The Pathology Meeting in Las Vegas
In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 4-5, 2026

View more
SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer
Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

View more
Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS

2

PMOS Awareness Month: Watch our expert panel discussion on PMOS

3

Phase 3 LUNA study: atogepant reduces menstrual migraine days vs. placebo

4

Kevin Ault, MD, on the clinician's role in maternal COVID-19 vaccine counseling

5

Society of Family Planning issues first guidance on deep and nonpalpable contraceptive implant removal

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us